In adults with overweight or obesity, weekly subcutaneous cagrilintide-semaglutide increased weight loss at 68 wk.

Agarwal, Arnav; Padwal, Raj; ACP Journal Club Editorial Team at McMaster University · Ann Intern Med · 2025

Where this comes from

Record sourced from PubMed, PMID 41052437.
Also identified by DOI 10.7326/ANNALS-25-03745-JC.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

GIM/FP/GP: [Formula: see text].

Read the full text

View on PubMed · Publisher (DOI)